S&P 500   3,375.47 (-0.14%)
DOW   27,897.91 (-0.28%)
QQQ   272.26 (+0.15%)
AAPL   458.63 (+1.46%)
MSFT   208.76 (-0.21%)
FB   260.43 (+0.21%)
GOOGL   1,516.87 (+0.64%)
AMZN   3,175.00 (+0.40%)
NVDA   456.88 (-0.16%)
CGC   17.28 (+0.17%)
BABA   253.71 (-0.58%)
TSLA   1,613.91 (+3.80%)
GE   6.61 (-1.64%)
MU   46.10 (-4.91%)
AMD   82.01 (-0.73%)
T   29.89 (-0.96%)
F   7.03 (-1.13%)
ACB   10.27 (+4.80%)
GILD   68.19 (-0.94%)
NFLX   481.93 (+1.36%)
DIS   131.13 (-0.50%)
BAC   26.26 (-1.76%)
BA   175.12 (-0.18%)
S&P 500   3,375.47 (-0.14%)
DOW   27,897.91 (-0.28%)
QQQ   272.26 (+0.15%)
AAPL   458.63 (+1.46%)
MSFT   208.76 (-0.21%)
FB   260.43 (+0.21%)
GOOGL   1,516.87 (+0.64%)
AMZN   3,175.00 (+0.40%)
NVDA   456.88 (-0.16%)
CGC   17.28 (+0.17%)
BABA   253.71 (-0.58%)
TSLA   1,613.91 (+3.80%)
GE   6.61 (-1.64%)
MU   46.10 (-4.91%)
AMD   82.01 (-0.73%)
T   29.89 (-0.96%)
F   7.03 (-1.13%)
ACB   10.27 (+4.80%)
GILD   68.19 (-0.94%)
NFLX   481.93 (+1.36%)
DIS   131.13 (-0.50%)
BAC   26.26 (-1.76%)
BA   175.12 (-0.18%)
S&P 500   3,375.47 (-0.14%)
DOW   27,897.91 (-0.28%)
QQQ   272.26 (+0.15%)
AAPL   458.63 (+1.46%)
MSFT   208.76 (-0.21%)
FB   260.43 (+0.21%)
GOOGL   1,516.87 (+0.64%)
AMZN   3,175.00 (+0.40%)
NVDA   456.88 (-0.16%)
CGC   17.28 (+0.17%)
BABA   253.71 (-0.58%)
TSLA   1,613.91 (+3.80%)
GE   6.61 (-1.64%)
MU   46.10 (-4.91%)
AMD   82.01 (-0.73%)
T   29.89 (-0.96%)
F   7.03 (-1.13%)
ACB   10.27 (+4.80%)
GILD   68.19 (-0.94%)
NFLX   481.93 (+1.36%)
DIS   131.13 (-0.50%)
BAC   26.26 (-1.76%)
BA   175.12 (-0.18%)
S&P 500   3,375.47 (-0.14%)
DOW   27,897.91 (-0.28%)
QQQ   272.26 (+0.15%)
AAPL   458.63 (+1.46%)
MSFT   208.76 (-0.21%)
FB   260.43 (+0.21%)
GOOGL   1,516.87 (+0.64%)
AMZN   3,175.00 (+0.40%)
NVDA   456.88 (-0.16%)
CGC   17.28 (+0.17%)
BABA   253.71 (-0.58%)
TSLA   1,613.91 (+3.80%)
GE   6.61 (-1.64%)
MU   46.10 (-4.91%)
AMD   82.01 (-0.73%)
T   29.89 (-0.96%)
F   7.03 (-1.13%)
ACB   10.27 (+4.80%)
GILD   68.19 (-0.94%)
NFLX   481.93 (+1.36%)
DIS   131.13 (-0.50%)
BAC   26.26 (-1.76%)
BA   175.12 (-0.18%)
Log in

LON:CSRTConsort Medical Price Target & Analyst Ratings

Add
Compare
Today's Range N/A
50-Day Range
1,010
MA: GBX 1,010
1,010
52-Week Range N/A
Volume770 shs
Average Volume23,005 shs
Market Capitalization£504.60 million
P/E Ratio127.85
Dividend Yield2.75%
BetaN/A

Analyst Ratings

Consort Medical (LON:CSRT) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for Consort Medical in the last 12 months. Their average twelve-month price target is GBX 1,010The high price target for CSRT is GBX 1,010 and the low price target for CSRT is GBX 1,010. There are currently 2 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 1,010GBX 1,010GBX 1,010GBX 1,010

Consort Medical (LON:CSRT) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Consort Medical (LON:CSRT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/10/2020Royal Bank of CanadaUpgradeSector Performer
11/18/2019Shore CapitalDowngradeHold
6/6/2019Numis SecuritiesDowngradeHold
12/5/2017N+1 SingerDowngradeHold
11/9/2017Stifel NicolausReiterated RatingBuyGBX 1,250
(Data available from 8/13/2018 forward)
This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.